{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:19:26Z","timestamp":1759580366691},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00277-016-2756-1","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T01:01:36Z","timestamp":1469667696000},"page":"1617-1625","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients"],"prefix":"10.1007","volume":"95","author":[{"given":"Tanapol","family":"Phondeechareon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Methichit","family":"Wattanapanitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowalak","family":"U-pratya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanapa","family":"Damkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuttha","family":"Klincumhom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanchao","family":"Lorthongpanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakpoom","family":"Kheolamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuti","family":"Laowtammathron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"issue":"1","key":"2756_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)81850-4","volume":"88","author":"L Luzzatto","year":"1997","unstructured":"Luzzatto L, Bessler M, Rotoli B (1997) Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell 88(1):1\u20134","journal-title":"Cell"},{"issue":"1","key":"2756_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1040-8428(99)00052-9","volume":"33","author":"P Boccuni","year":"2000","unstructured":"Boccuni P, Del Vecchio L, Di Noto R, Rotoli B (2000) Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria. Crit Rev Oncol Hematol 33(1):25\u201343","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"2756_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.exphem.2007.01.046","volume":"35","author":"CJ Parker","year":"2007","unstructured":"Parker CJ (2007) The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol 35(4):523\u2013533. doi: 10.1016\/j.exphem.2007.01.046","journal-title":"Exp Hematol"},{"issue":"2","key":"2756_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.blre.2007.10.002","volume":"22","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA (2008) Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria. Blood Rev 22(2):65\u201374. doi: 10.1016\/j.blre.2007.10.002","journal-title":"Blood Rev"},{"issue":"1","key":"2756_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.2830250108","volume":"25","author":"S Issaragrisil","year":"1987","unstructured":"Issaragrisil S, Piankijagum A, Tang-naitrisorana Y (1987) Corticosteroids therapy in paroxysmal nocturnal hemoglobinuria. Am J Hematol 25(1):77\u201383","journal-title":"Am J Hematol"},{"issue":"6","key":"2756_CR6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.V66.6.1247.1247","volume":"66","author":"JH Antin","year":"1985","unstructured":"Antin JH, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM (1985) Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 66(6):1247\u20131250","journal-title":"Blood"},{"issue":"2","key":"2756_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1600-0609.2003.00097.x","volume":"71","author":"JL Lee","year":"2003","unstructured":"Lee JL, Lee JH, Choi SJ, Kim S, Seol M, Lee YS, Chi HS, Park CJ, Kim WK, Lee JS, Lee KH (2003) Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol 71(2):114\u2013118","journal-title":"Eur J Haematol"},{"issue":"11","key":"2756_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1083","volume":"9","author":"U Hegenbart","year":"2003","unstructured":"Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L, Ponisch W, Epner E, Witherspoon R, Blume K, Storb R (2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 9(11):689\u2013697. doi: 10.1016\/S1083","journal-title":"Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"2756_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2141.2006.06019.x","volume":"133","author":"R Srinivasan","year":"2006","unstructured":"Srinivasan R, Takahashi Y, McCoy JP, Espinoza-Delgado I, Dorrance C, Igarashi T, Lundqvist A, Barrett AJ, Young NS, Geller N, Childs RW (2006) Overcoming graft rejection in heavily transfused and Allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 133(3):305\u2013314. doi: 10.1111\/j.1365-2141.2006.06019.x","journal-title":"Br J Haematol"},{"issue":"9","key":"2756_CR10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.bbmt.2014.05.012","volume":"20","author":"J Pantin","year":"2014","unstructured":"Pantin J, Tian X, Geller N, Ramos C, Cook L, Cho E, Scheinberg P, Vasu S, Khuu H, Stroncek D, Barrett J, Young NS, Donohue T, Childs RW (2014) Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant 20(9):1435\u20131439. doi: 10.1016\/j.bbmt.2014.05.012","journal-title":"Biol Blood Marrow Transplant : J Am Soc Blood Marrow Transplant"},{"issue":"6","key":"2756_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa031688","volume":"350","author":"P Hillmen","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350(6):552\u2013559. doi: 10.1056\/NEJMoa031688","journal-title":"N Engl J Med"},{"issue":"4","key":"2756_CR12","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle L, de Castro C, CL F, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P (2008) Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111(4):1840\u20131847. doi: 10.1182\/blood-2007-06-094136","journal-title":"Blood"},{"key":"2756_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/asheducation-2011.1.21","volume":"2011","author":"CJ Parker","year":"2011","unstructured":"Parker CJ (2011) Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. Hematol \/ Educ Program Am Soc Hematol Am Soc Hematol Educ Program 2011:21\u201329. doi: 10.1182\/asheducation-2011.1.21","journal-title":"Hematol \/ Educ Program Am Soc Hematol Am Soc Hematol Educ Program"},{"issue":"25","key":"2756_CR14","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117(25):6786\u20136792. doi: 10.1182\/blood-2011-02-333997","journal-title":"Blood"},{"issue":"1","key":"2756_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bjh.12347","volume":"162","author":"P Hillmen","year":"2013","unstructured":"Hillmen P, Muus P, Roth A, Elebute MO, Risitano AM, Schrezenmeier H, Szer J, Browne P, Maciejewski JP, Schubert J, Urbano-Ispizua A, de Castro C, Socie G, Brodsky RA (2013) Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 162(1):62\u201373. doi: 10.1111\/bjh.12347","journal-title":"Br J Haematol"},{"issue":"9","key":"2756_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106952","volume":"9","author":"M Wattanapanitch","year":"2014","unstructured":"Wattanapanitch M, Klincumhom N, Potirat P, Amornpisutt R, Lorthongpanich C, U-pratya Y, Laowtammathron C, Kheolamai P, Poungvarin N, Issaragrisil S (2014) Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages. PLoS One 9(9):e106952. doi: 10.1371\/journal.pone.0106952","journal-title":"PLoS One"},{"issue":"4","key":"2756_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/biores.2012.0242","volume":"1","author":"K Pruksananonda","year":"2012","unstructured":"Pruksananonda K, Rungsiwiwut R, Numchaisrika P, Ahnonkitpanit V, Isarasena N, Virutamasen P (2012) Eighteen-year cryopreservation does not negatively affect the pluripotency of human embryos: evidence from embryonic stem cell derivation. BioRes Open Access 1(4):166\u2013173. doi: 10.1089\/biores.2012.0242","journal-title":"BioRes Open Access"},{"issue":"3","key":"2756_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1182\/blood-2012-11-466722","volume":"122","author":"BW Smith","year":"2013","unstructured":"Smith BW, Rozelle SS, Leung A, Ubellacker J, Parks A, Nah SK, French D, Gadue P, Monti S, Chui DH, Steinberg MH, Frelinger AL, Michelson AD, Theberge R, McComb ME, Costello CE, Kotton DN, Mostoslavsky G, Sherr DH, Murphy GJ (2013) The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 122(3):376\u2013385. doi: 10.1182\/blood-2012-11-466722","journal-title":"Blood"},{"key":"2756_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1095-9","author":"Z Ye","year":"2012","unstructured":"Ye Z, Chou BK, Cheng L (2012) Promise and challenges of human iPSC-based hematologic disease modeling and treatment. Int J Hematol. doi: 10.1007\/s12185-012-1095-9","journal-title":"Int J Hematol"},{"issue":"2","key":"2756_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1566523211313020002","volume":"13","author":"E Bayart","year":"2013","unstructured":"Bayart E, Cohen-Haguenauer O (2013) Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther 13(2):73\u201392","journal-title":"Curr Gene Ther"},{"issue":"4","key":"2756_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrg2937","volume":"12","author":"F Gonzalez","year":"2011","unstructured":"Gonzalez F, Boue S, Izpisua Belmonte JC (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12(4):231\u2013242. doi: 10.1038\/nrg2937","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2756_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1517\/14712590903455989","volume":"10","author":"L Shao","year":"2010","unstructured":"Shao L, WS W (2010) Gene-delivery systems for iPS cell generation. Expert Opin Biol Ther 10(2):231\u2013242. doi: 10.1517\/14712590903455989","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"2756_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.stem.2008.11.008","volume":"3","author":"N Maherali","year":"2008","unstructured":"Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3(6):595\u2013605. doi: 10.1016\/j.stem.2008.11.008","journal-title":"Cell Stem Cell"},{"issue":"7151","key":"2756_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313\u2013317. doi: 10.1038\/nature05934","journal-title":"Nature"},{"issue":"1","key":"2756_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26(1):101\u2013106. doi: 10.1038\/nbt1374","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2756_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nbt.1554","volume":"27","author":"K Miura","year":"2009","unstructured":"Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S (2009) Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27(8):743\u2013745. doi: 10.1038\/nbt.1554","journal-title":"Nat Biotechnol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2756-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2756-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2756-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T11:57:19Z","timestamp":1600948639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2756-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["2756"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2756-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}